- Curriculum Vitae
- Office hour
Born in Reggio Calabria on July 24, 1975; he lives in Parma. Married with two daughters.
Antonino Musolino is Associate Professor of Medical Oncology at the University of Parma, Italy. He is also Head of the Breast Unit, University Hospital of Parma.
His initial medical training was in Messina, Italy. Then, he moved to the University Hospital of Parma for specialist training in Cancer Medicine and, later, to the University Hospital of Padua for specialist training in Hematology. He also spent some time in London at the Royal Marsden Hospital (Gastrointestinal Cancer and Lymphoma Units, Head: Prof. David Cunningham). He achieved the PhD in Pathophysiology in 2009 at the University of Parma and the Master of Science in Epidemiology in 2017 at the University of Turin. His principal clinical and research interests are breast cancer, lymphomas, cancer epidemiology and pharmacogenetics.
Over the past 15 years he has become increasingly involved in clinical trials, pharmacogenetics, and epidemiological studies focusing on individualized treatments for HER2-positive breast cancer. He is currently Principal Investigator for several international multicenter breast cancer trials involving in particular targeted therapies. He publishes and lectures extensively. He was awarded the American Association for Cancer Research (AACR) Scholar-in-Training Award in recognition of promising cancer research at the 2007 AACR annual meeting and Elsevier Recognized Reviewer from 2016 to 2020.
Prof. Musolino is President of the Italian Oncology Group of Clinical Research (GOIRC), and member of the Breast International Group (BIG) task force on early clinical research.
Anno accademico di erogazione: 2024/2025
- Course year: 3 - Full cicle (6 years) - MEDICINE AND SURGERY - A.Y.: 2022/2023
Anno accademico di erogazione: 2022/2023
- Course year: 3 - First cycle degree (DM 270) - BIOMEDICAL LABORATORY TECHNIQUES - A.Y.: 2020/2021
Anno accademico di erogazione: 2021/2022
- Course year: 3 - First cycle degree (DM 270) - BIOMEDICAL LABORATORY TECHNIQUES - A.Y.: 2019/2020
Anno accademico di erogazione: 2020/2021
- Course year: 3 - First cycle degree (DM 270) - BIOMEDICAL LABORATORY TECHNIQUES - A.Y.: 2018/2019
Anno accademico di erogazione: 2019/2020
- Course year: 3 - First cycle degree (DM 270) - BIOMEDICAL LABORATORY TECHNIQUES - A.Y.: 2017/2018
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J.Year: in stampaAuthor/s: MUSOLINO, Antonino, MISSALE, Gabriele, NERI, Tauro Maria
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 TrialYear: 2022Author/s: MUSOLINO, Antonino
Year: 2022Author/s: TOMMASI, CHIARA, PELLEGRINO, BENEDETTA, MUSOLINO, Antonino
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task ForceYear: 2022Author/s: MUSOLINO, Antonino
Year: 2022Author/s: PELLEGRINO, BENEDETTA, BOGGIANI, Daniela, SIKOKIS, ANGELICA, ULIANA, Vera, TOMMASI, CHIARA, MUSOLINO, Antonino